ArticleNPJ precision oncology2022

Pharmacometabolomics reveals urinary diacetylspermine as a biomarker of doxorubicin effectiveness in triple negative breast cancer.

Thomas J Velenosi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.